141 related articles for article (PubMed ID: 29908109)
1. [Drug glucuronidation and disposition in brain].
Zhang ZQ; Sheng L; Li Y
Yao Xue Xue Bao; 2016 Nov; 51(11):1674-80. PubMed ID: 29908109
[TBL] [Abstract][Full Text] [Related]
2. Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).
Knights KM; Rowland A; Miners JO
Br J Clin Pharmacol; 2013 Oct; 76(4):587-602. PubMed ID: 23362865
[TBL] [Abstract][Full Text] [Related]
3. Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors.
den Braver-Sewradj SP; den Braver MW; Baze A; Decorde J; Fonsi M; Bachellier P; Vermeulen NPE; Commandeur JNM; Richert L; Vos JC
Eur J Pharm Sci; 2017 Nov; 109():96-110. PubMed ID: 28778465
[TBL] [Abstract][Full Text] [Related]
4. The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure.
Zhang M; Rottschäfer V; C M de Lange E
Drug Metab Rev; 2024 Feb; 56(1):1-30. PubMed ID: 38126313
[TBL] [Abstract][Full Text] [Related]
5. Predicting reactivity to drug metabolism: beyond P450s-modelling FMOs and UGTs.
Öeren M; Walton PJ; Hunt PA; Ponting DJ; Segall MD
J Comput Aided Mol Des; 2021 Apr; 35(4):541-555. PubMed ID: 32533369
[TBL] [Abstract][Full Text] [Related]
6. In vitro interaction of a novel neutrophil growth factor with human liver microsomal cytochromes P450 and the contribution of UDP-glucuronosyltransferases to its metabolism.
Siller M; Anzenbacher P; Anzenbacherová E; Doležal K; Strnad M
Xenobiotica; 2011 Nov; 41(11):934-44. PubMed ID: 21745145
[TBL] [Abstract][Full Text] [Related]
7. Modulation of UDP-glucuronosyltransferase activity by protein-protein association.
Ishii Y; Takeda S; Yamada H
Drug Metab Rev; 2010 Feb; 42(1):145-58. PubMed ID: 19817679
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450-mediated metabolism of triclosan attenuates its cytotoxicity in hepatic cells.
Wu Y; Chitranshi P; Loukotková L; Gamboa da Costa G; Beland FA; Zhang J; Fang JL
Arch Toxicol; 2017 Jun; 91(6):2405-2423. PubMed ID: 27896399
[TBL] [Abstract][Full Text] [Related]
9. Metabolic assessment in liver microsomes by co-activating cytochrome P450s and UDP-glycosyltransferases.
Yan Z; Caldwell GW
Eur J Drug Metab Pharmacokinet; 2003; 28(3):223-32. PubMed ID: 14527096
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory Effects of Selected Antituberculosis Drugs on Common Human Hepatic Cytochrome P450 and UDP-glucuronosyltransferase Enzymes.
Cao L; Greenblatt DJ; Kwara A
Drug Metab Dispos; 2017 Sep; 45(9):1035-1043. PubMed ID: 28663285
[TBL] [Abstract][Full Text] [Related]
11. Glucuronidation enzymes, genes and psychiatry.
de Leon J
Int J Neuropsychopharmacol; 2003 Mar; 6(1):57-72. PubMed ID: 12899737
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Atlas of Cytochrome P450, UDP-Glucuronosyltransferase, and Transporter Proteins in Jejunum of Morbidly Obese Subjects.
Miyauchi E; Tachikawa M; Declèves X; Uchida Y; Bouillot JL; Poitou C; Oppert JM; Mouly S; Bergmann JF; Terasaki T; Scherrmann JM; Lloret-Linares C
Mol Pharm; 2016 Aug; 13(8):2631-40. PubMed ID: 27347605
[TBL] [Abstract][Full Text] [Related]
13. Identification of human cytochrome P450 and UGT enzymes involved in the metabolism of ferulic acid, a major bioactive component in traditional Chinese medicines.
Zhuang XM; Chen L; Tan Y; Yang HY; Lu C; Gao Y; Li H
Chin J Nat Med; 2017 Sep; 15(9):695-702. PubMed ID: 28991531
[TBL] [Abstract][Full Text] [Related]
14. Relation of Transcriptional Factors to the Expression and Activity of Cytochrome P450 and UDP-Glucuronosyltransferases 1A in Human Liver: Co-Expression Network Analysis.
Zhong S; Han W; Hou C; Liu J; Wu L; Liu M; Liang Z; Lin H; Zhou L; Liu S; Tang L
AAPS J; 2017 Jan; 19(1):203-214. PubMed ID: 27681103
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition.
Zheng YF; Bae SH; Choi EJ; Park JB; Kim SO; Jang MJ; Park GH; Shin WG; Oh E; Bae SK
Food Chem Toxicol; 2014 Jun; 68():117-27. PubMed ID: 24632066
[TBL] [Abstract][Full Text] [Related]
16. [Protein-Protein Interactions as Underlying Regulatory Mechanisms of Drug-metabolizing Enzyme Function].
Miyauchi Y
Yakugaku Zasshi; 2022; 142(11):1169-1175. PubMed ID: 36328446
[TBL] [Abstract][Full Text] [Related]
17. Inter-donor variability of phase I/phase II metabolism of three reference drugs in cryopreserved primary human hepatocytes in suspension and monolayer.
den Braver-Sewradj SP; den Braver MW; Vermeulen NP; Commandeur JN; Richert L; Vos JC
Toxicol In Vitro; 2016 Jun; 33():71-9. PubMed ID: 26921663
[TBL] [Abstract][Full Text] [Related]
18. Synthetic cannabinoids are substrates and inhibitors of multiple drug-metabolizing enzymes.
Kong TY; Kim JH; Kim DK; Lee HS
Arch Pharm Res; 2018 Jul; 41(7):691-710. PubMed ID: 30039377
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases by MAM-2201 in human liver microsomes.
Kong TY; Kim JH; Kwon SS; Cheong JC; Kim HS; In MK; Lee HS
Arch Pharm Res; 2017 Jun; 40(6):727-735. PubMed ID: 28484907
[TBL] [Abstract][Full Text] [Related]
20. UDP-glucuronosyltransferases (UGTs) and their related metabolic cross-talk with internal homeostasis: A systematic review of UGT isoforms for precision medicine.
Yang N; Sun R; Liao X; Aa J; Wang G
Pharmacol Res; 2017 Jul; 121():169-183. PubMed ID: 28479371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
